Israel can live with — and even benefit from– the Iranian nuclear deal. Can Netanyahu?
CNS’s scientist-in-residence discusses the ways the Iran deal closes all possible routes to the bomb.
Occasional Paper #23: CNS researchers offer governments a roadmap to replace high-risk radioactive sources with non-isotopic alternatives.
The deal may not be ideal, but when viewed in historical and hypothetical context, it is incredibly strong.
The Iran deal is merely a first step toward a long-term process of managing the nuclear risks it poses.
Statements by Rose Gottemoeller, US undersecretary of state for arms control & Lassina Zerbo, executive secretary of the Comprehensive Test-Ban Treaty
The P5+1 needs to be assured that even if Iran expels inspectors and enriches enough uranium for a bomb, there is time for a sufficient response to be organized.
Experts from CNS and VCDNP are available for comment on a range of aspects pertaining to the final Iran nuclear deal and its implications.
Analysis of images of the Pyongyang Bio-technical Institute reveals North Korea can produce regular, military-sized batches of biological weapons, specifically anthrax.
A self-proclaimed lapsed philosopher offers a liberal’s view of effective foreign policy for the twenty-first century.
